US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

INDIVIOR PLC

35.03

-0.6600-1.85%

Volume:878.40K

Turnover:30.67M

Market Cap:4.13B

PE:12.66

High:35.62

Open:35.59

Low:34.59

Close:35.69

52wk High:42.81

52wk Low:22.22

Shares:118.00M

Float Shares:116.45M

Volume Ratio:0.45

T/O Rate:0.75%

Dividend:- -

Dividend Rate:- -

EPS(TTM):2.77

EPS(LYR):1.64

ROE:12.20%

ROA:26.40%

PB:-19.87

PE(LYR):21.36

Loading ...

Overview Company News Filings

Indivior Q1 GAAP net income rises 89% to $89 million; revenue climbs 19% to $317 million

Indivior Q1 Adj. EPS $0.96 Beats $0.66 Estimate, Sales $317.000M Beat $272.840M Estimate

Benzinga Earnings

Indivior Pharmaceuticals, Inc - Revises FY 2026 Net Revenue Guidance to $1,215 Mln-$1,285 Mln

THOMSON REUTERS

Indivior Pharmaceuticals, Inc - Revises FY 2026 Adj Ebitda Guidance to $620 Mln-$660 Mln

THOMSON REUTERS

Indivior Pharmaceuticals, Inc - Revises FY 2026 Sublocade Net Revenue Guidance to $950 Mln-$990 Mln

THOMSON REUTERS

Addex Therapeutics publishes 2025 annual report

Addex FY25 net loss widens to CHF 6.7 million; cash falls to CHF 1.6 million

Evaluating Indivior Pharmaceuticals (NasdaqGS:INDV) After New ASAM 2026 Data On Sublocade Effectiveness

Simply Wall St.

Indivior study links Sublocade-based OUD remission to better quality-of-life outcomes

Does Indivior (INDV) Survey Support For Long-Acting Buprenorphine Strengthen Its Criminal Justice Strategy?

Simply Wall St.

Indivior survey finds 88% of jail staff back injectable buprenorphine to curb diversion

Could Indivior (INDV) Turn Correctional Staffing Efficiencies Into a Durable Competitive Edge?

Simply Wall St.

Indivior to report Q1 financial results, host webcast update

Press Release: Indivior to Report First Quarter 2026 Financial Results and Host Webcast on April 30th

Indivior model shows monthly Sublocade cuts jail MOUD staffing time versus methadone, oral buprenorphine

REFILE-FOCUS-Drugmakers delay some European launches with a wary eye on Trump's pricing policies

Indivior announces annual shareholder meeting; FY2025 total net revenue rises to $1.2 billion

Top Premarket Gainers

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigerfiesta.com/stock/INDV/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"INDV","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INDV\",,,,,undefined,":{"symbol":"INDV","market":"US","secType":"STK","nameCN":"INDIVIOR PLC","latestPrice":35.03,"timestamp":1789757240037,"preClose":35.69,"halted":0,"volume":878404,"delay":0,"changeRate":-0.018492574950966564,"floatShares":116454522,"shares":118000000,"eps":2.766067,"marketStatus":"Trading","change":-0.66,"latestTime":"09-18 14:47:24 EDT","open":35.59,"high":35.615,"low":34.59,"amount":30671138.478772003,"amplitude":0.02872,"askPrice":35.04,"askSize":261,"bidPrice":35.02,"bidSize":77,"shortable":3,"etf":0,"ttmEps":2.766067,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789761600000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":35.69,"preHourTrading":{"tag":"盘前","latestPrice":35.63,"preClose":35.69,"latestTime":"09:29 EDT","volume":4067,"amount":143827.523175,"timestamp":1789738199999,"change":-0.06,"changeRate":-0.001681,"amplitude":0.039227},"postHourTrading":{"tag":"盘后","latestPrice":35.69,"preClose":35.69,"latestTime":"19:49 EDT","volume":1052918,"amount":37578649.285,"timestamp":1789688970204,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.449486,"impliedVol":0.3426,"impliedVolPercentile":0.1275},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INDV\",,,,,undefined,":{"symbol":"INDV","floatShares":116454522,"roa":"26.40%","roe":"12.20%","lyrEps":1.64,"volumeRatio":0.449486,"shares":118000000,"dividePrice":0,"high":35.615,"amplitude":0.02872,"preClose":35.69,"low":34.59,"week52Low":22.22,"pbRate":"-19.87","psRate":"3.11","week52High":42.81,"institutionHeld":0,"latestPrice":35.03,"committee":-0.544379,"eps":2.766067,"divideRate":0,"volume":878404,"delay":0,"ttmEps":2.766067,"open":35.59,"prevYearClose":35.88,"prevWeekClose":34.49,"prevMonthClose":34.93,"prevQuarterClose":41.03,"fiveDayClose":34.49,"twentyDayClose":37.78,"sixtyDayClose":41.47,"dividendPayoutRate":1.9539525374644688,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0.02676056338028169},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/INDV\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-03","symbol":"INDV","fiscalQuarterEnding":"2026/06","expectedEps":0.97,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1785729600000,"reportTimeType":"pre","actualEps":1.15},{"market":"US","date":"2026-04-30","symbol":"INDV","fiscalQuarterEnding":"2026/03","expectedEps":0.64,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1777521600000,"reportTimeType":"pre","actualEps":0.96},{"market":"US","date":"2026-02-26","symbol":"INDV","fiscalQuarterEnding":"2025/12","expectedEps":0.65,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1772082000000,"reportTimeType":"pre","actualEps":0.82},{"market":"US","date":"2026-01-26","symbol":"INDV","reason":null,"defaultRemindTime":1769437800000,"announcedDate":"2026-01-23","type":"delisting","dateTimestamp":1769403600000},{"market":"US","date":"2025-10-30","symbol":"INDV","fiscalQuarterEnding":"2025/09","expectedEps":0.38,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1761796800000,"reportTimeType":"pre","actualEps":0.72}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"INDV\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"INDV\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.75,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.75,"analysts":4,"updateTime":1781841600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/INDV\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"INDV","date":"2026-09-17","current":12.512351,"percent":0.421374,"low":-539.080629,"twenty":-24.965008,"median":17.925445,"eighty":56.217043,"high":1520.868351,"avg":86.729834,"sd":411.465944,"marketCap":4053768843},"quantilePoints":[{"date":"2024-01-05","current":-8.731325,"twenty":-8.731325,"median":-8.731325,"eighty":-8.731325,"marketCap":2051861355.61},{"date":"2024-01-12","current":-9.061129,"twenty":-8.930914,"median":-8.915467,"eighty":-8.872434,"marketCap":2129365213.58},{"date":"2024-01-19","current":-9.036937,"twenty":-9.037083,"median":-8.926675,"eighty":-8.867596,"marketCap":2123680078.16},{"date":"2024-01-26","current":-10.054308,"twenty":-9.927259,"median":-9.036937,"eighty":-8.901284,"marketCap":2362762158.39},{"date":"2024-02-02","current":-10.004449,"twenty":-10.01442,"median":-9.223686,"eighty":-8.919649,"marketCap":2351045521.54},{"date":"2024-02-09","current":-10.098427,"twenty":-10.051065,"median":-9.895497,"eighty":-8.929219,"marketCap":2373130321.56},{"date":"2024-02-16","current":-10.175342,"twenty":-10.179852,"median":-9.943541,"eighty":-8.977536,"marketCap":2391205561.35},{"date":"2024-02-23","current":1442.16344,"twenty":-10.183288,"median":-9.929623,"eighty":-8.965881,"marketCap":2884326878.5},{"date":"2024-03-01","current":1520.868351,"twenty":-10.175772,"median":-9.860171,"eighty":-8.862758,"marketCap":3041736702.67},{"date":"2024-03-08","current":1456.331845,"twenty":-10.129193,"median":-9.478841,"eighty":1456.594636,"marketCap":2912663689.17},{"date":"2024-03-15","current":1406.519641,"twenty":-10.071956,"median":-9.037667,"eighty":1456.594636,"marketCap":2813039280.38},{"date":"2024-03-22","current":1416.408463,"twenty":-10.051876,"median":-8.960053,"eighty":1447.830802,"marketCap":2832816924.48},{"date":"2024-03-28","current":1455.260447,"twenty":-10.040734,"median":-8.915467,"eighty":1455.903286,"marketCap":2910520894.48},{"date":"2024-04-05","current":1458.075233,"twenty":-10.017652,"median":-8.848243,"eighty":1457.639065,"marketCap":2916150468.02},{"date":"2024-04-12","current":1329.065563,"twenty":-9.996443,"median":1356.65224,"eighty":1456.726031,"marketCap":2658131124.79},{"date":"2024-04-19","current":1279.103138,"twenty":-9.969287,"median":1309.349865,"eighty":1455.903286,"marketCap":2558206276.88},{"date":"2024-04-26","current":476.533403,"twenty":-9.944147,"median":1284.511395,"eighty":1452.111517,"marketCap":2382667015.68},{"date":"2024-05-03","current":485.430033,"twenty":-9.931801,"median":1275.015426,"eighty":1446.43078,"marketCap":2427150166.81},{"date":"2024-05-10","current":484.77744,"twenty":-9.909437,"median":493.219646,"eighty":1443.862237,"marketCap":2423887197.01},{"date":"2024-05-17","current":457.733314,"twenty":-9.881367,"median":488.116405,"eighty":1441.351048,"marketCap":2288666574.17},{"date":"2024-05-24","current":465.20437,"twenty":-9.858941,"median":485.295631,"eighty":1439.871356,"marketCap":2326021847.95},{"date":"2024-05-31","current":496.261466,"twenty":-9.799964,"median":486.27573,"eighty":1436.258175,"marketCap":2481307333.36},{"date":"2024-06-07","current":439.995107,"twenty":-9.5344,"median":485.430033,"eighty":1423.367779,"marketCap":2199975534.13},{"date":"2024-06-14","current":451.615042,"twenty":-9.386243,"median":484.77744,"eighty":1423.350602,"marketCap":2258075214.65},{"date":"2024-06-21","current":447.135681,"twenty":-9.126152,"median":483.175553,"eighty":1421.904534,"marketCap":2235678403.11},{"date":"2024-06-28","current":420.240739,"twenty":-9.056437,"median":482.881297,"eighty":1420.903799,"marketCap":2101203699.91},{"date":"2024-07-05","current":399.169394,"twenty":-9.037667,"median":478.317711,"eighty":1418.346927,"marketCap":1995846972.62},{"date":"2024-07-12","current":281.71779,"twenty":-9.036937,"median":474.886858,"eighty":1416.476807,"marketCap":1408588947.59},{"date":"2024-07-15","current":269.124484,"twenty":-9.027388,"median":474.396895,"eighty":1416.463138,"marketCap":1345622420.31},{"date":"2024-08-02","current":-12.681184,"twenty":-9.037375,"median":474.162636,"eighty":1416.449469,"marketCap":1788046959.52},{"date":"2024-08-09","current":-11.831658,"twenty":-9.742833,"median":463.001654,"eighty":1415.475285,"marketCap":1668263747.87},{"date":"2024-08-16","current":-11.531835,"twenty":-9.931801,"median":456.721797,"eighty":1411.053167,"marketCap":1625988694.51},{"date":"2024-08-23","current":-11.359567,"twenty":-10.017652,"median":455.124507,"eighty":1403.016644,"marketCap":1601698904.31},{"date":"2024-08-30","current":-11.517339,"twenty":-10.144576,"median":449.847335,"eighty":1394.819348,"marketCap":1623944812.52},{"date":"2024-09-06","current":-9.739044,"twenty":-10.190159,"median":447.535315,"eighty":1390.076063,"marketCap":1373205236.08},{"date":"2024-09-13","current":-9.093341,"twenty":-10.176202,"median":437.901092,"eighty":1388.200752,"marketCap":1282161095.35},{"date":"2024-09-20","current":-8.695405,"twenty":-10.159959,"median":436.792984,"eighty":1385.619667,"marketCap":1226052087.81},{"date":"2024-09-27","current":-9.187795,"twenty":-10.089603,"median":420.240739,"eighty":1373.204246,"marketCap":1295479177.06},{"date":"2024-10-04","current":-9.452398,"twenty":-10.053497,"median":411.279432,"eighty":1328.888735,"marketCap":1332788098.86},{"date":"2024-10-11","current":-6.894174,"twenty":-10.045494,"median":397.767615,"eighty":1324.41511,"marketCap":972078462.1},{"date":"2024-10-18","current":-7.729502,"twenty":-10.022053,"median":275.421137,"eighty":1306.911197,"marketCap":1089859827.76},{"date":"2024-10-25","current":-387.254131,"twenty":-10.022053,"median":258.931158,"eighty":1295.294828,"marketCap":1161762392.56},{"date":"2024-10-31","current":-376.128091,"twenty":-10.098427,"median":-6.913465,"eighty":1287.84805,"marketCap":1128384273.39},{"date":"2024-11-08","current":-434.650258,"twenty":-10.197534,"median":-7.218189,"eighty":1281.174739,"marketCap":1303950773.11},{"date":"2024-11-15","current":-417.553766,"twenty":-10.357169,"median":-7.68996,"eighty":1279.103138,"marketCap":1252661295.74},{"date":"2024-11-22","current":-455.401138,"twenty":-11.279742,"median":-7.770979,"eighty":1275.015426,"marketCap":1366203413.46},{"date":"2024-11-29","current":-475.483527,"twenty":-11.472459,"median":-8.119915,"eighty":1262.088941,"marketCap":1426450581.27},{"date":"2024-12-06","current":-462.637374,"twenty":-11.520238,"median":-8.577538,"eighty":649.987226,"marketCap":1387912124.34},{"date":"2024-12-13","current":-484.970807,"twenty":-11.624468,"median":-8.706737,"eighty":497.452148,"marketCap":1454912419.5},{"date":"2024-12-20","current":-483.00699,"twenty":-11.880785,"median":-8.81707,"eighty":496.483725,"marketCap":1449020970.4},{"date":"2024-12-27","current":-524.024438,"twenty":-12.457859,"median":-8.855646,"eighty":495.297532,"marketCap":1572073311.64},{"date":"2025-01-03","current":-526.020236,"twenty":-230.749328,"median":-8.892068,"eighty":493.586593,"marketCap":1578060706.99},{"date":"2025-01-10","current":-497.27008,"twenty":-384.916258,"median":-8.907363,"eighty":491.400602,"marketCap":1491810238.16},{"date":"2025-01-17","current":-486.412641,"twenty":-393.098632,"median":-8.915467,"eighty":488.91137,"marketCap":1459237922.85},{"date":"2025-01-24","current":-489.294402,"twenty":-425.635451,"median":-8.960053,"eighty":488.290719,"marketCap":1467883205.21},{"date":"2025-01-31","current":-495.059612,"twenty":-434.650258,"median":-9.004691,"eighty":488.174377,"marketCap":1485178837.55},{"date":"2025-02-07","current":-398.440394,"twenty":-438.198605,"median":-9.035763,"eighty":488.116405,"marketCap":1195321181.39},{"date":"2025-02-14","current":-410.047551,"twenty":-437.752568,"median":-9.061129,"eighty":487.121427,"marketCap":1230142653.13},{"date":"2025-02-21","current":-22.522233,"twenty":-439.344773,"median":-9.095438,"eighty":485.768312,"marketCap":1081067217.57},{"date":"2025-02-28","current":-22.859537,"twenty":-437.841775,"median":-9.294936,"eighty":485.214989,"marketCap":1097257759.94},{"date":"2025-03-07","current":-24.283428,"twenty":-437.023459,"median":-9.444366,"eighty":484.854198,"marketCap":1165604557.36},{"date":"2025-03-14","current":605.149026,"twenty":-435.088443,"median":-9.294936,"eighty":488.127999,"marketCap":1210298050.41},{"date":"2025-03-21","current":-25.271265,"twenty":-433.037368,"median":-9.386243,"eighty":488.197645,"marketCap":1213020698.87},{"date":"2025-03-28","current":-24.738754,"twenty":-430.777799,"median":-9.448382,"eighty":488.127999,"marketCap":1187460219.29},{"date":"2025-04-04","current":-24.352592,"twenty":-427.288281,"median":-9.739044,"eighty":487.320423,"marketCap":1168924445.9},{"date":"2025-04-11","current":-23.146184,"twenty":-425.814745,"median":-9.877834,"eighty":485.768312,"marketCap":1111016863.05},{"date":"2025-04-17","current":-23.722243,"twenty":-421.727469,"median":-9.929623,"eighty":485.26875,"marketCap":1138667669.28},{"date":"2025-04-25","current":-21.827382,"twenty":-418.181119,"median":-9.984433,"eighty":484.930955,"marketCap":1353297690.88},{"date":"2025-05-02","current":-23.745782,"twenty":-414.153201,"median":-10.038354,"eighty":483.882407,"marketCap":1472238458.47},{"date":"2025-05-09","current":-22.159707,"twenty":-410.782993,"median":-10.098427,"eighty":483.219619,"marketCap":1373901817.96},{"date":"2025-05-16","current":-22.569779,"twenty":-408.327019,"median":-10.185005,"eighty":482.998999,"marketCap":1399326293.84},{"date":"2025-05-23","current":-22.3193,"twenty":-401.936236,"median":-10.311545,"eighty":482.806461,"marketCap":1383796581.45},{"date":"2025-05-30","current":-25.63971,"twenty":-396.501678,"median":-10.3517,"eighty":480.981026,"marketCap":1589662006.96},{"date":"2025-06-06","current":-27.767026,"twenty":-393.177531,"median":-11.138759,"eighty":477.603988,"marketCap":1721555638.78},{"date":"2025-06-13","current":-28.024212,"twenty":-392.348167,"median":-11.279742,"eighty":476.07077,"marketCap":1737501138.51},{"date":"2025-06-20","current":-28.284472,"twenty":-391.855975,"median":-11.446173,"eighty":475.180835,"marketCap":1753637267.93},{"date":"2025-06-27","current":-27.245913,"twenty":-390.345823,"median":-11.490318,"eighty":474.303192,"marketCap":1689246563.77},{"date":"2025-07-03","current":-31.054113,"twenty":-387.254131,"median":-11.508717,"eighty":473.928378,"marketCap":1925355009.01},{"date":"2025-07-11","current":-31.171056,"twenty":-387.002934,"median":-11.55631,"eighty":465.20437,"marketCap":1932605447.05},{"date":"2025-07-18","current":-32.333828,"twenty":-385.010735,"median":-11.628362,"eighty":463.001654,"marketCap":2004697356.56},{"date":"2025-07-25","current":-33.722781,"twenty":-384.538351,"median":-11.705533,"eighty":457.733314,"marketCap":2090812381.22},{"date":"2025-08-01","current":47.55378,"twenty":-383.933492,"median":-11.954476,"eighty":457.459813,"marketCap":2520350364},{"date":"2025-08-08","current":51.908953,"twenty":-383.123313,"median":-11.661073,"eighty":455.983781,"marketCap":2751174531},{"date":"2025-08-15","current":54.545599,"twenty":-376.128091,"median":-11.608831,"eighty":455.390371,"marketCap":2890916729},{"date":"2025-08-22","current":56.617249,"twenty":-35.016046,"median":-11.531835,"eighty":455.124507,"marketCap":3000714171},{"date":"2025-08-29","current":56.217043,"twenty":-34.774556,"median":-11.495509,"eighty":452.199783,"marketCap":2979503301},{"date":"2025-09-05","current":58.218069,"twenty":-34.549166,"median":-11.478929,"eighty":451.73199,"marketCap":3085557648},{"date":"2025-09-12","current":56.217043,"twenty":-34.412321,"median":-11.359567,"eighty":448.786711,"marketCap":2979503301},{"date":"2025-09-19","current":53.886437,"twenty":-33.856664,"median":-11.154173,"eighty":447.963884,"marketCap":2855981179},{"date":"2025-09-26","current":53.698106,"twenty":-33.722781,"median":-10.357169,"eighty":447.295534,"marketCap":2845999594},{"date":"2025-10-03","current":54.757472,"twenty":-33.367838,"median":-10.329434,"eighty":441.423222,"marketCap":2902146013},{"date":"2025-10-10","current":56.852663,"twenty":-32.522883,"median":-10.193594,"eighty":438.319895,"marketCap":3013191153},{"date":"2025-10-17","current":58.123903,"twenty":-32.191426,"median":-10.136885,"eighty":437.230259,"marketCap":3080566855},{"date":"2025-10-24","current":59.51285,"twenty":-31.936305,"median":-10.050254,"eighty":437.029825,"marketCap":3154181049},{"date":"2025-10-31","current":49.115471,"twenty":-31.768326,"median":-9.994441,"eighty":436.655789,"marketCap":3634544856},{"date":"2025-11-07","current":53.771536,"twenty":-31.614854,"median":-9.940515,"eighty":432.826301,"marketCap":3979093697},{"date":"2025-11-14","current":50.329618,"twenty":-31.467797,"median":-9.877834,"eighty":422.57095,"marketCap":3724391747},{"date":"2025-11-21","current":53.602815,"twenty":-31.224616,"median":-9.739044,"eighty":418.358561,"marketCap":3966608307},{"date":"2025-11-28","current":33.831379,"twenty":-31.10089,"median":-9.452398,"eighty":417.079998,"marketCap":4195090939},{"date":"2025-12-05","current":34.838265,"twenty":-31.035365,"median":-9.406482,"eighty":410.227055,"marketCap":4319944836},{"date":"2025-12-12","current":36.036459,"twenty":-30.949051,"median":-9.187795,"eighty":401.908655,"marketCap":4468520973},{"date":"2025-12-19","current":35.784738,"twenty":-30.882422,"median":-9.077235,"eighty":398.328327,"marketCap":4437307499},{"date":"2025-12-26","current":36.409007,"twenty":-30.838389,"median":-9.037302,"eighty":355.290696,"marketCap":4514716915},{"date":"2026-01-02","current":36.127079,"twenty":-30.768476,"median":-9.020236,"eighty":289.603812,"marketCap":4479757824},{"date":"2026-01-09","current":35.754531,"twenty":-30.593054,"median":-8.994538,"eighty":279.199129,"marketCap":4433561882},{"date":"2026-01-16","current":33.111455,"twenty":-30.162922,"median":-8.926675,"eighty":268.955119,"marketCap":4105820402},{"date":"2026-01-23","current":33.770965,"twenty":-29.887031,"median":-8.908086,"eighty":268.277658,"marketCap":4187599705},{"date":"2026-01-30","current":34.949022,"twenty":-29.648103,"median":-8.907363,"eighty":262.669758,"marketCap":4333678764},{"date":"2026-02-06","current":34.687232,"twenty":-28.870039,"median":-8.882251,"eighty":139.280173,"marketCap":4301216751},{"date":"2026-02-13","current":33.99248,"twenty":-28.353691,"median":-8.848243,"eighty":59.385726,"marketCap":4215067562},{"date":"2026-02-20","current":34.677163,"twenty":-28.238411,"median":-8.731325,"eighty":59.244477,"marketCap":4299968212},{"date":"2026-02-27","current":20.042023,"twenty":-28.144728,"median":-8.655829,"eighty":59.018479,"marketCap":4208824867},{"date":"2026-03-06","current":19.087338,"twenty":-28.07439,"median":-8.478095,"eighty":58.74069,"marketCap":4008341006},{"date":"2026-03-13","current":18.378635,"twenty":-27.9958,"median":-7.827701,"eighty":58.632399,"marketCap":3859513368},{"date":"2026-03-20","current":18.164238,"twenty":-27.926913,"median":-7.703119,"eighty":58.505275,"marketCap":3814489881},{"date":"2026-03-27","current":17.836686,"twenty":-27.874039,"median":-7.514349,"eighty":58.29811,"marketCap":3745703997},{"date":"2026-04-02","current":17.794815,"twenty":-27.836472,"median":-6.995266,"eighty":58.236902,"marketCap":3736911077},{"date":"2026-04-10","current":18.758579,"twenty":-27.751968,"median":-6.894174,"eighty":58.199236,"marketCap":3939301693},{"date":"2026-04-17","current":18.294115,"twenty":-27.679313,"median":16.982644,"eighty":58.114486,"marketCap":3841764047},{"date":"2026-04-24","current":19.252074,"twenty":-27.620734,"median":17.503178,"eighty":58.072112,"marketCap":4042935443},{"date":"2026-05-01","current":17.794815,"twenty":-27.559726,"median":17.69031,"eighty":58.025029,"marketCap":4484293293},{"date":"2026-05-08","current":19.159181,"twenty":-27.4491,"median":17.730951,"eighty":57.88378,"marketCap":4828113496},{"date":"2026-05-15","current":18.302823,"twenty":-27.391357,"median":17.815751,"eighty":57.742531,"marketCap":4612311454},{"date":"2026-05-22","current":18.123811,"twenty":-27.288803,"median":17.836686,"eighty":57.620115,"marketCap":4567200292},{"date":"2026-05-29","current":17.712566,"twenty":-27.245913,"median":17.896416,"eighty":57.582449,"marketCap":4463566543},{"date":"2026-06-05","current":18.118973,"twenty":-27.042075,"median":17.815751,"eighty":57.417659,"marketCap":4565981072},{"date":"2026-06-12","current":18.447969,"twenty":-26.689807,"median":17.954474,"eighty":57.347034,"marketCap":4648888071},{"date":"2026-06-18","current":18.351205,"twenty":-26.089973,"median":18.089943,"eighty":57.271701,"marketCap":4624503659},{"date":"2026-06-26","current":19.976832,"twenty":-25.921332,"median":18.140745,"eighty":57.196369,"marketCap":5034161774},{"date":"2026-07-02","current":19.473662,"twenty":-25.822694,"median":18.173171,"eighty":57.168119,"marketCap":4907362834},{"date":"2026-07-10","current":19.981671,"twenty":-25.687845,"median":18.198802,"eighty":56.975079,"marketCap":5035380995},{"date":"2026-07-17","current":19.63816,"twenty":-25.580272,"median":18.293631,"eighty":56.852663,"marketCap":4948816334},{"date":"2026-07-24","current":19.599455,"twenty":-25.493702,"median":18.346367,"eighty":56.796163,"marketCap":4939062569},{"date":"2026-07-31","current":19.459148,"twenty":-25.451449,"median":18.378635,"eighty":56.749081,"marketCap":4903705172},{"date":"2026-08-07","current":12.819067,"twenty":-25.369514,"median":18.324595,"eighty":56.725539,"marketCap":4563587806},{"date":"2026-08-14","current":12.669892,"twenty":-25.215019,"median":18.293147,"eighty":56.692581,"marketCap":4510481664},{"date":"2026-08-21","current":12.524033,"twenty":-25.098157,"median":18.192754,"eighty":56.645498,"marketCap":4458555659},{"date":"2026-08-28","current":11.701915,"twenty":-25.029903,"median":18.164238,"eighty":56.579583,"marketCap":4165881809},{"date":"2026-09-04","current":11.546111,"twenty":-24.99181,"median":18.121392,"eighty":56.438333,"marketCap":4110415394},{"date":"2026-09-11","current":11.440031,"twenty":-24.975865,"median":18.055625,"eighty":56.292376,"marketCap":4072651026},{"date":"2026-09-17","current":11.386991,"twenty":-24.965008,"median":17.925445,"eighty":56.217043,"marketCap":4053768843}],"updateTime":1789745047918},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"INDV\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2631636892","title":"Indivior Q1 GAAP net income rises 89% to $89 million; revenue climbs 19% to $317 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2631636892","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631636892?lang=en_us&edition=fundamental","pubTime":"2026-04-30 19:08","pubTimestamp":1777547338,"startTime":"0","endTime":"0","summary":"Indivior posted Q1 2026 GAAP net income of $89 million, compared with $123 million in non-GAAP net income.Adjusted EBITDA more than doubled to $164 million.SUBLOCADE net revenue climbed 32% to $232 million, driven by 20% dispense unit volume growth.Full-year 2026 guidance was raised to revenue of $1.22 billion-$1.29 billion and adjusted EBITDA of $620 million-$660 million.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Indivior Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 30, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nNDL4XpQWM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","INDV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631463561","title":"Indivior Q1 Adj. EPS $0.96 Beats $0.66 Estimate, Sales $317.000M Beat $272.840M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2631463561","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631463561?lang=en_us&edition=fundamental","pubTime":"2026-04-30 19:02","pubTimestamp":1777546946,"startTime":"0","endTime":"0","summary":"Indivior (NASDAQ:INDV) reported quarterly earnings of $0.96 per share which beat the analyst consensus estimate of $0.66 by 45.45 percent. This is a 134.15 percent increase over earnings of $0.41 per share from the same","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/04/52164174/indivior-q1-adj-eps-0-96-beats-0-66-estimate-sales-317-000m-beat-272-840m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INDV","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631635789","title":"Indivior Pharmaceuticals, Inc - Revises FY 2026 Net Revenue Guidance to $1,215 Mln-$1,285 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2631635789","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631635789?lang=en_us&edition=fundamental","pubTime":"2026-04-30 19:00","pubTimestamp":1777546805,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nPLX771921:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","INDV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631635732","title":"Indivior Pharmaceuticals, Inc - Revises FY 2026 Adj Ebitda Guidance to $620 Mln-$660 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2631635732","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631635732?lang=en_us&edition=fundamental","pubTime":"2026-04-30 19:00","pubTimestamp":1777546805,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nPLX771921:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["INDV","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631352756","title":"Indivior Pharmaceuticals, Inc - Revises FY 2026 Sublocade Net Revenue Guidance to $950 Mln-$990 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2631352756","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631352756?lang=en_us&edition=fundamental","pubTime":"2026-04-30 19:00","pubTimestamp":1777546805,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nPLX771921:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["INDV","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631064045","title":"Addex Therapeutics publishes 2025 annual report","url":"https://stock-news.laohu8.com/highlight/detail?id=2631064045","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631064045?lang=en_us&edition=fundamental","pubTime":"2026-04-30 13:28","pubTimestamp":1777526912,"startTime":"0","endTime":"0","summary":"Addex Therapeutics published its annual report for 2025, highlighting progress in chronic cough and brain injury recovery programs.Indivior completed IND-enabling studies for selected GABAB PAM candidate in substance use disorder under existing partnership.Addex reported its independently selected GABAB PAM candidate showed robust anti-tussive effects across several preclinical models for chronic cough.Company signed option and collaboration agreement with Sinntaxis on April 30, 2025 to secure exclusive IP license covering use of mGlu5 inhibitors in brain injury recovery.Addex regained full development and commercialization rights to Phase 2 mGlu2 PAM asset ADX71149 from Johnson and Johnson.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advic","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nNDL6TntrR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2756315318.SGD","LU1674673691.USD","IE00BN8TJ469.HKD","LU2756315664.SGD","LU2471134952.CNY","LU1043141123.HKD","LU0426412945.USD","IE00B1BXHZ80.USD","LU0795875086.SGD","JNJ","LU1267930813.SGD","LU2213496289.HKD","LU1551013342.USD","IE00BVYPNV92.GBP","IE00B19Z3B42.SGD","IE000MB6IJN5.SGD","LU0345769631.USD","LU0058720904.USD","LU1221951046.USD","LU0820561818.USD","LU1121112475.USD","BK4581","LU0683600562.USD","LU1894683264.USD","IE00B3PB1722.GBP","LU1244550494.USD","LU1066051225.USD","LU1496350502.SGD","LU1074936037.SGD","IE00BKVL7J92.USD","SG9999001176.USD","LU0203347892.USD","IE00B19Z3581.USD","LU0320765646.SGD","LU1506573853.SGD","LU1935042991.SGD","LU1059921491.USD","IE00B3T34201.USD","LU2592432038.USD","INDV","LU1914381329.SGD","SG9999002224.SGD","IE00B4R5TH58.HKD","IE0001KFT4U8.USD","IE00BDGV0183.EUR","LU2471134796.USD","BK4588","LU2487616109.SGD","LU1280957306.USD","LU0234570918.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631450524","title":"Addex FY25 net loss widens to CHF 6.7 million; cash falls to CHF 1.6 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2631450524","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631450524?lang=en_us&edition=fundamental","pubTime":"2026-04-30 13:02","pubTimestamp":1777525339,"startTime":"0","endTime":"0","summary":"Addex posted a net loss of CHF 6.73 million in 2025, swinging from a prior-year profit as discontinued-operations profit fell to CHF 114,000.Revenue declined 57.8% to CHF 173,000 due to completion of the research phase of its Indivior collaboration on June 30, 2024.Operating loss widened to CHF 2.82 million as G&A held at CHF 2.32 million despite R&D easing to CHF 672,000.Cash slipped to CHF 1.64 million at year-end from a CHF 1.7 million net cash decrease during the year, while shareholders’ equity fell to CHF 4.77 million.Operationally, Addex advanced its GABAB PAM chronic cough candidate toward the clinic and continued repositioning dipraglurant for brain injury recovery, with CEO Tim Dyer citing “robust and sustained progress” and no financial outlook provided.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nNDL9VRBZX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2W23.USD","NDAQ","BK4007","IE00B3QW5Z07.USD","IE00BN0W2T93.GBP","IE00BN0W2V16.EUR","LU2210150020.SGD","IE00B64PRP62.GBP","SG9999014005.SGD","SG9999014021.USD","BK4585","IE00BKPKM429.USD","INDV","SG9999014039.USD","LU0314104364.USD","IE00BGHQF748.EUR","SG9999014013.SGD","BK4588","LU2210149790.SGD","BK4112","LU2095319765.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630032126","title":"Evaluating Indivior Pharmaceuticals (NasdaqGS:INDV) After New ASAM 2026 Data On Sublocade Effectiveness","url":"https://stock-news.laohu8.com/highlight/detail?id=2630032126","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630032126?lang=en_us&edition=fundamental","pubTime":"2026-04-28 13:06","pubTimestamp":1777352819,"startTime":"0","endTime":"0","summary":"Indivior Pharmaceuticals (INDV) drew fresh investor attention after presenting new real world data at the ASAM 2026 Annual Conference in San Diego on its monthly extended release buprenorphine treatment, SUBLOCADE, for opioid use disorder.\nSee our latest analysis for Indivior Pharmaceuticals.\nThose ASAM data arrive at a time when Indivior Pharmaceuticals’ share price has shown an 18.43% 1 month share price return but remains slightly weaker year to date, while a very large 1 year total...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-indv/indivior-pharmaceuticals/news/evaluating-indivior-pharmaceuticals-nasdaqgsindv-after-new-a","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-indv/indivior-pharmaceuticals/news/evaluating-indivior-pharmaceuticals-nasdaqgsindv-after-new-a","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["INDV","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629828725","title":"Indivior study links Sublocade-based OUD remission to better quality-of-life outcomes","url":"https://stock-news.laohu8.com/highlight/detail?id=2629828725","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629828725?lang=en_us&edition=fundamental","pubTime":"2026-04-24 23:01","pubTimestamp":1777042916,"startTime":"0","endTime":"0","summary":"Indivior presented new real-world findings at ASAM 2026 on April 24, 2026, highlighting clinical benefits of monthly injectable buprenorphine  in opioid use disorder.Ontario health-data analysis of more than 45,000 patients linked higher time on medication treatment to fewer overdose events versus time off treatment.Study also indicated buprenorphine-based options, including SUBLOCADE, were associated with lower overdose risk versus no medication treatment.Separate ROUTE study provisional results in 443 participants tied remission on SUBLOCADE to improved patient-relevant outcomes such as reduced craving and better quality of life.Readout supported remission as a treatment endpoint beyond abstinence, reinforcing Indivior strategy around long-acting injectable buprenorphine.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260424:nNDLc2Q2vl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2W23.USD","LU0314104364.USD","NDAQ","BK4007","IE00BGHQF748.EUR","BK4588","BK4112","LU2210150020.SGD","SG9999014013.SGD","BK4585","IE00B3QW5Z07.USD","LU2095319765.USD","IE00BN0W2V16.EUR","INDV","LU2210149790.SGD","IE00BKPKM429.USD","IE00BN0W2T93.GBP","SG9999014039.USD","SG9999014005.SGD","IE00B64PRP62.GBP","SG9999014021.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628875051","title":"Does Indivior (INDV) Survey Support For Long-Acting Buprenorphine Strengthen Its Criminal Justice Strategy?","url":"https://stock-news.laohu8.com/highlight/detail?id=2628875051","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628875051?lang=en_us&edition=fundamental","pubTime":"2026-04-19 09:09","pubTimestamp":1776560990,"startTime":"0","endTime":"0","summary":"In April 2026, Indivior PLC reported results from a national survey showing that correctional leaders see staffing and coordination gaps as major barriers to preventing diversion of medications for opioid use disorder, and view long-acting injectable buprenorphine as a practical way to improve treatment in jails and prisons.\nThe survey’s strong support among correctional professionals for long-acting injectable buprenorphine highlights a potential opportunity for wider use of Indivior’s...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-indv/indivior-pharmaceuticals/news/does-indivior-indv-survey-support-for-long-acting-buprenorph","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-indv/indivior-pharmaceuticals/news/does-indivior-indv-survey-support-for-long-acting-buprenorph","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4007","INDV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628243979","title":"Indivior survey finds 88% of jail staff back injectable buprenorphine to curb diversion","url":"https://stock-news.laohu8.com/highlight/detail?id=2628243979","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628243979?lang=en_us&edition=fundamental","pubTime":"2026-04-17 02:36","pubTimestamp":1776364618,"startTime":"0","endTime":"0","summary":"Indivior announced results from a national survey published in Journal of Correctional Health Care that assessed approaches to limit misuse of medications for opioid use disorder in US jails and prisons.Survey findings indicated correctional leaders view long-acting injectable buprenorphine as a way to curb medication diversion while supporting treatment delivery.Most respondents in both jail and prison settings reported that monthly injectable dosing could help reduce misuse inside facilities.Responses also pointed to staffing constraints and weak coordination between custody and health teams as major barriers to effective opioid treatment programs.Cost and access concerns were cited as key obstacles that could limit adoption despite perceived operational benefits.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260416:nNDL8tK8qQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INDV","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626165124","title":"Could Indivior (INDV) Turn Correctional Staffing Efficiencies Into a Durable Competitive Edge?","url":"https://stock-news.laohu8.com/highlight/detail?id=2626165124","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626165124?lang=en_us&edition=fundamental","pubTime":"2026-04-10 11:38","pubTimestamp":1775792330,"startTime":"0","endTime":"0","summary":"Indivior Pharmaceuticals recently reported that a new cost impact model, published in The Journal of Current Medical Research and Opinion, found its monthly injectable SUBLOCADE® could significantly reduce staff time and related costs for treating opioid use disorder in U.S. jails and prisons versus other medication options.\nThe study’s suggestion that extended-release buprenorphine may ease operational burdens in correctional healthcare could influence policymakers and institutional buyers...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-indv/indivior-pharmaceuticals/news/could-indivior-indv-turn-correctional-staffing-efficiencies","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-indv/indivior-pharmaceuticals/news/could-indivior-indv-turn-correctional-staffing-efficiencies","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4007","INDV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626186423","title":"Indivior to report Q1 financial results, host webcast update","url":"https://stock-news.laohu8.com/highlight/detail?id=2626186423","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626186423?lang=en_us&edition=fundamental","pubTime":"2026-04-09 19:03","pubTimestamp":1775732617,"startTime":"0","endTime":"0","summary":"Indivior schedules Q1 2026 financial results release for April 30, 2026 at 7:00 a.m. EDT.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260409:nNDL8gYV3x:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","IE00B3QW5Z07.USD","INDV","BK4585","IE00BN0W2W23.USD","IE00BKPKM429.USD","SG9999014005.SGD","LU2210150020.SGD","IE00BGHQF748.EUR","LU2095319765.USD","IE00BN0W2T93.GBP","BK4588","IE00BN0W2V16.EUR","SG9999014013.SGD","SG9999014039.USD","BK4007","BK4112","SG9999014021.USD","LU2210149790.SGD","LU0314104364.USD","IE00B64PRP62.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626186150","title":"Press Release: Indivior to Report First Quarter 2026 Financial Results and Host Webcast on April 30th","url":"https://stock-news.laohu8.com/highlight/detail?id=2626186150","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626186150?lang=en_us&edition=fundamental","pubTime":"2026-04-09 19:00","pubTimestamp":1775732400,"startTime":"0","endTime":"0","summary":"RICHMOND, Va., April 09, 2026  -- Indivior Pharmaceuticals, Inc.  today announced that it will report its first quarter 2026 financial results on Thursday, April 30, 2026, at 7:00 a.m. U.S. EDT. Following the release of the financial results, Joe Ciaffoni, Chief Executive Officer, and other members of Indivior's leadership team will host a presentation via live webcast at 8:00 a.m. U.S. EDT.The webcast event and materials can be accessed on the \"Investors\" section of the company's website at www.indivior.com before the event begins.Participants may access the presentation telephonically by registering with the following link:. A replay of the presentation will be available at www.indivior.com.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4218","HST","BK4585","BK4007","INDV","BK4588","BK4181"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624564305","title":"Indivior model shows monthly Sublocade cuts jail MOUD staffing time versus methadone, oral buprenorphine","url":"https://stock-news.laohu8.com/highlight/detail?id=2624564305","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624564305?lang=en_us&edition=fundamental","pubTime":"2026-04-01 06:12","pubTimestamp":1774995136,"startTime":"0","endTime":"0","summary":"Indivior-backed cost impact model estimated monthly injectable buprenorphine  could cut staff time in jails and prisons versus methadone, oral buprenorphine, weekly extended-release buprenorphine, or extended-release naltrexone.Model projected 318 fewer staff hours per month per 100 patients versus methadone.Staffing requirement fell by 747 hours versus oral buprenorphine.Reduced staff time translated into monthly cost savings of up to USD 22,148, driven by less daily observed dosing and fewer patient escorts.Study flagged limits, including exclusion of drug acquisition costs.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Indivior Pharmaceuticals Inc. published the original content used to generate this news brief on March 31, 2026, a","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nNDLbL1QlT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INDV","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623970308","title":"REFILE-FOCUS-Drugmakers delay some European launches with a wary eye on Trump's pricing policies","url":"https://stock-news.laohu8.com/highlight/detail?id=2623970308","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623970308?lang=en_us&edition=fundamental","pubTime":"2026-03-31 14:00","pubTimestamp":1774936800,"startTime":"0","endTime":"0","summary":"REFILE-FOCUS-Drugmakers delay some European launches with a wary eye on Trump's pricing policiesCorrects typographical error in anti-inflammatory drug name Brinsupri in paragraph 15Trump most-favored-nation deals cause pricing uncertaintyData shows 35% drop in European new drug launchesCompanies say they want more clarity on US prices first Situation bolsters US position as first go-to marketEurope needs to rethink drug pricing to stay competitive, lobby group saysBy Maggie Fick, Bhanvi Satija and Dominique Patton","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nL4N40D163:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0211327993.USD","LU1983299246.USD","LU2108987350.USD","LU0960981461.USD","LU2089984988.USD","LU0972486137.USD","LU0823416689.USD","AMGN","LU0211326839.USD","LU2125909593.SGD","LU1880407132.USD","LU2089283258.USD","LU1496350171.SGD","LU0047473722.EUR","LU1291159041.SGD","LU1170363599.USD","LU0310800379.SGD","BK4533","LU1064927863.SGD","LU0792757196.USD","03165","LU1153585028.USD","LU1301847155.USD","LU1487256676.USD","LU0496365809.HKD","AZN.UK","SG9999001176.SGD","LU0077335932.USD","INDV","LU0545039389.USD","LU2293690082.USD","LU1196032939.SGD","LU2112291526.USD","LU0320765992.SGD","LU2242652126.USD","SG9999001176.USD","IE00B3T34201.USD","BK4566","LU0949170426.SGD","LU0345777659.USD","LU1989772923.USD","INSM","LU1989771016.USD","LU0029864427.USD","LU0963555726.SGD","LU0868494617.USD","LU0889565080.SGD","LU0266013472.USD","LU1153584641.USD","LU0047473722.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622847221","title":"Indivior announces annual shareholder meeting; FY2025 total net revenue rises to $1.2 billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2622847221","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622847221?lang=en_us&edition=fundamental","pubTime":"2026-03-27 18:07","pubTimestamp":1774606037,"startTime":"0","endTime":"0","summary":"Indivior will hold its annual meeting on May 13, 2026, via a virtual meeting platform.Shareholders will vote on the election of eight directors to one-year terms.An advisory vote will be held on named executive officer compensation.An advisory vote will be held on the preferred frequency of future executive compensation votes.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Indivior Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 27, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nNDL4xXxXs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INDV","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621770727","title":"Top Premarket Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2621770727","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621770727?lang=en_us&edition=fundamental","pubTime":"2026-03-23 19:34","pubTimestamp":1774265667,"startTime":"0","endTime":"0","summary":"Apogee Therapeutics  stock was up 18% pre-bell Monday after the company said that 52-week maintenance data from Part A of its phase two trial of zumilokibart in patients with moderate-to-severe atopic dermatitis demonstrated durable maintenance response and \"deepening\" response for lesional and itch endpoints.Indivior  shares were 13% higher following a 3.9% loss in the previous session.Synopsys  stock was up 4.2% after media reports over the weekend that Elliott Investment Management has built a multibillion-dollar stake in the company.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1861214812.USD","LU0082616367.USD","LU2125909247.SGD","LU1861215975.USD","LU1951200564.SGD","LU2063271972.USD","IE00BKPKM429.USD","LU1815333072.USD","LU0957791311.USD","LU0390134368.USD","LU0109392836.USD","LU0444971666.USD","LU1989764664.SGD","LU1642822529.SGD","SG9999004303.SGD","LU1923622614.USD","LU0719512351.SGD","LU0053671581.USD","LU1861219969.SGD","SGXZ99366536.SGD","LU0096362180.USD","LU1923622291.USD","IE00BZ199S13.USD","LU0347712357.USD","LU2360107168.USD","LU0957808578.USD","LU1303367103.USD","LU1815336760.USD","LU2458330169.SGD","BK4585","APGE","LU2413666426.HKD","LU0889565833.HKD","BK4023","LU1854103824.USD","LU2247934214.USD","BK4139","LU1989764748.USD","LU2125909593.SGD","SNPX","LU1721428933.USD","BK4588","BK4533","LU2433249047.HKD","LU2290526834.HKD","SGXZ51526630.SGD","INDV","SNPS","BK4007","LU0061474960.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":5,"totalSize":98,"code":"91000000","status":"200"}]}}